Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 1,500 shares, an increase of 7.1% from the March 15th total of 1,400 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 22,000 shares, the short-interest ratio is presently 0.1 days.
Hedge Funds Weigh In On Bellevue Life Sciences Acquisition
Several institutional investors and hedge funds have recently bought and sold shares of BLAC. UBS Group AG bought a new position in Bellevue Life Sciences Acquisition during the 1st quarter worth approximately $82,000. Condor Capital Management bought a new stake in shares of Bellevue Life Sciences Acquisition in the 4th quarter worth approximately $121,000. Cowen AND Company LLC bought a new stake in shares of Bellevue Life Sciences Acquisition in the 4th quarter worth approximately $165,000. Wealthspring Capital LLC bought a new stake in shares of Bellevue Life Sciences Acquisition in the 3rd quarter worth approximately $209,000. Finally, Toroso Investments LLC bought a new stake in shares of Bellevue Life Sciences Acquisition in the 3rd quarter worth approximately $313,000. 55.30% of the stock is currently owned by institutional investors.
Bellevue Life Sciences Acquisition Stock Performance
BLAC opened at $10.70 on Wednesday. The stock’s 50 day simple moving average is $10.64 and its 200 day simple moving average is $10.54. Bellevue Life Sciences Acquisition has a 1 year low of $10.11 and a 1 year high of $11.16.
Bellevue Life Sciences Acquisition Company Profile
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp.
Further Reading
- Five stocks we like better than Bellevue Life Sciences Acquisition
- What Investors Need to Know to Beat the Market
- Silicon Motion Proves That AI in Motion Stays in Motion
- There Are Different Types of Stock To Invest In
- Undervalued UnitedHealth Group Won’t Be For Long
- Best Aerospace Stocks Investing
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
